We are live on
!
Find out more
MC
Mayo Clinic Portfolio holdings
AUM
$2.9M
1-Year Est. Return
14.49%
This Fund
S&P 500
This Quarter
Est. Return
+30.64%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.15M
AUM Growth
-$10M
(-62%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-175.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perspective Therapeutics
CATX
|
+$618K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$10.1M |
| 2 |
Immunome
IMNM
|
+$1.16M |
| 3 |
Scilex Holding
SCLX
|
+$86.3K |
| 4 |
ImmunityBio
IBRX
|
+$7.04K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 68.89% |
| 2 | Miscellaneous | 31.11% |
Similar funds
SWS
PWA
CU
QC
SOA
HVM
JC
MIG
Mayo Clinic's Q1 2024 Portfolio in Review
As of Q1 2024, Mayo Clinic held 8 positions worth $6.15M, down 62% from $16.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mayo Clinic withdrew a net $10.8M in Q1 2024, closing 3 positions and reducing 1 holding. Its most notable exit was Immunome, an estimated $1.16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 29% a quarter earlier, followed by Miscellaneous.
Against the trend, Mayo Clinic opened a new position in Perspective Therapeutics worth $862K.
- Mayo Clinic's largest Q1 2024 buy was Perspective Therapeutics: 72,464 shares worth $862K.
- Mayo Clinic's biggest Q1 2024 reduction was iShares MSCI ACWI ETF, cutting an estimated $10.1M.
- Mayo Clinic fully exited Immunome in Q1 2024, selling an estimated $1.16M.
- Mayo Clinic's ten largest holdings make up 100% of its $6.15M portfolio in Q1 2024.
- Mayo Clinic opened 1 new position and closed 3 in Q1 2024.
- Mayo Clinic's portfolio value fell 62% quarter-over-quarter to $6.15M.
Based on Mayo Clinic's 13F filing for Q1 2024, filed 13 May 2024.